1925 related articles for article (PubMed ID: 18539529)
1. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.
Prado CM; Lieffers JR; McCargar LJ; Reiman T; Sawyer MB; Martin L; Baracos VE
Lancet Oncol; 2008 Jul; 9(7):629-35. PubMed ID: 18539529
[TBL] [Abstract][Full Text] [Related]
2. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.
Martin L; Birdsell L; Macdonald N; Reiman T; Clandinin MT; McCargar LJ; Murphy R; Ghosh S; Sawyer MB; Baracos VE
J Clin Oncol; 2013 Apr; 31(12):1539-47. PubMed ID: 23530101
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
Anandavadivelan P; Brismar TB; Nilsson M; Johar AM; Martin L
Clin Nutr; 2016 Jun; 35(3):724-30. PubMed ID: 26065721
[TBL] [Abstract][Full Text] [Related]
4. Fat and fat-free mass as important determinants of body composition assessment in relation to sarcopenic obesity.
Gažarová M; Bihari M; Šoltís J
Rocz Panstw Zakl Hig; 2023; 74(1):59-69. PubMed ID: 37010407
[TBL] [Abstract][Full Text] [Related]
5. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
Dijksterhuis WPM; Pruijt MJ; van der Woude SO; Klaassen R; Kurk SA; van Oijen MGH; van Laarhoven HWM
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):199-206. PubMed ID: 30666831
[TBL] [Abstract][Full Text] [Related]
6. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer.
Awad S; Tan BH; Cui H; Bhalla A; Fearon KC; Parsons SL; Catton JA; Lobo DN
Clin Nutr; 2012 Feb; 31(1):74-7. PubMed ID: 21875767
[TBL] [Abstract][Full Text] [Related]
7. [The prevalence of sarcopenic obesity in postmenopausal women in depending on the used methodology - preliminary study].
Milewska M; Sińska B; Sych D; Kucharska A
Pol Merkur Lekarski; 2015 Apr; 38(226):206-10. PubMed ID: 25938387
[TBL] [Abstract][Full Text] [Related]
8. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review.
Donini LM; Busetto L; Bauer JM; Bischoff S; Boirie Y; Cederholm T; Cruz-Jentoft AJ; Dicker D; Frühbeck G; Giustina A; Gonzalez MC; Han HS; Heymsfield SB; Higashiguchi T; Laviano A; Lenzi A; Parrinello E; Poggiogalle E; Prado CM; Rodriguez JS; Rolland Y; Santini F; Siervo M; Tecilazich F; Vettor R; Yu J; Zamboni M; Barazzoni R
Clin Nutr; 2020 Aug; 39(8):2368-2388. PubMed ID: 31813698
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenic obesity by the ESPEN/EASO criteria for predicting mortality in advanced non-small cell lung cancer.
Zhou J; Luo L; Xie L; Hu S; Tan L; Lei X; Luo X; Yang M
Clin Nutr; 2023 Jun; 42(6):817-824. PubMed ID: 37084468
[TBL] [Abstract][Full Text] [Related]
10. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
Lodewick TM; van Nijnatten TJ; van Dam RM; van Mierlo K; Dello SA; Neumann UP; Olde Damink SW; Dejong CH
HPB (Oxford); 2015 May; 17(5):438-46. PubMed ID: 25512239
[TBL] [Abstract][Full Text] [Related]
11. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
12. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.
Fukuda T; Bouchi R; Takeuchi T; Tsujimoto K; Minami I; Yoshimoto T; Ogawa Y
Cardiovasc Diabetol; 2018 Apr; 17(1):55. PubMed ID: 29636045
[TBL] [Abstract][Full Text] [Related]
14. Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients.
Kroh A; Uschner D; Lodewick T; Eickhoff RM; Schöning W; Ulmer FT; Neumann UP; Binnebösel M
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):28-37. PubMed ID: 30115516
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenic obesity and its association with respiratory disease incidence and mortality.
Petermann-Rocha F; Yang S; Gray SR; Pell JP; Celis-Morales C; Ho FK
Clin Nutr; 2020 Nov; 39(11):3461-3466. PubMed ID: 32204975
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of sarcopenic obesity in adults with end-stage knee osteoarthritis.
Godziuk K; Prado CM; Woodhouse LJ; Forhan M
Osteoarthritis Cartilage; 2019 Dec; 27(12):1735-1745. PubMed ID: 31276820
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy.
Baracos VE; Arribas L
Ann Oncol; 2018 Feb; 29(suppl_2):ii1-ii9. PubMed ID: 29506228
[TBL] [Abstract][Full Text] [Related]
18. Simplified method of clinical phenotyping for older men and women using established field-based measures.
Fukuda DH; Smith-Ryan AE; Kendall KL; Moon JR; Stout JR
Exp Gerontol; 2013 Dec; 48(12):1479-88. PubMed ID: 24140621
[TBL] [Abstract][Full Text] [Related]
19. Understanding factors associated with sarcopenic obesity in older African women from a low-income setting: a cross-sectional analysis.
Mendham AE; Goedecke JH; Micklesfield LK; Brooks NE; Faber M; Christensen DL; Gallagher IJ; Lundin-Olsson L; Myburgh KH; Odunitan-Wayas FA; Lambert EV; Kalula S; Hunter AM
BMC Geriatr; 2021 Apr; 21(1):247. PubMed ID: 33853546
[TBL] [Abstract][Full Text] [Related]
20. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity.
Chung JY; Kang HT; Lee DC; Lee HR; Lee YJ
Arch Gerontol Geriatr; 2013; 56(1):270-8. PubMed ID: 23079031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
